Trusted Supply of Critical & Orphan Medicines, Worldwide!

Drug: Ridaforolimus
Brand: Taltorvic 40mg
Manufacturer /
TM Owner
Merck & Co.
Origin: USA

Taltorvic 40mg Tablet

Taltorvic is a prescription immunosuppressant based on Ridaforolimus. It dampens immune activity to prevent organ rejection or control autoimmune disease. It is used in the treatment of a range of cancers. It is supplied as a tablet (40mg). It offers patients a well-established, evidence-based option prescribed and monitored by specialists.
Strength: 40mg
Pack Size: 30s
Storage: 20°C to 25°C
Form: Tablet

+91 900 500 9556

Global Shipping : Reliable Global Distribution Network

Express Delivery : Priority Shipping for Every Order

Secure Payments : Trusted Payment Protection System

Disclaimer
All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the 'Manufacturer/ TM Owner' section in compliance with statutory requirements. Read More

Secure Handling

24/7 Worldwide Support

Global Access

Worldwide Access to Health

Cold-Chain Expert

Excellence in Cold-Chain

Trusted Supply

Certified Medical Supply

Indications & Clinical Uses

  • Taltorvic was a proposed brand name for ridaforolimus, an mTOR-inhibitor cancer drug that has never been approved by any regulator.
  • Ridaforolimus was studied in clinical trials for advanced soft-tissue and bone sarcoma.
  • The FDA declined approval in June 2012 after an advisory committee voted against it, and the European marketing application was withdrawn in November 2012.
  • There is no approved indication, prescribing information or marketed product under the name Taltorvic.

Side Effects

  • Because ridaforolimus was never approved, there is no official label listing its side effects.
  • Clinical trials reported effects typical of mTOR inhibitors, such as mouth sores and low blood counts.
  • These findings come from research data and not from approved prescribing information.

Precautions & Warnings

  • No approved product exists under this name, so do not obtain or take any product sold online as Taltorvic.
  • If you were prescribed Taltorvic, contact your prescriber and pharmacist to confirm the intended medicine, as the name may be misheard, misspelled or outdated.
  • No dosing, storage or safety guidance can be given because no regulatory label exists.
  • Ask your oncologist which currently approved option suits your type of sarcoma.

Avoid Interactions

  • No interaction information is available because there is no approved label for ridaforolimus.
  • Tell your doctor and pharmacist about all medicines and supplements you take before starting any cancer treatment.

References

Frequently Asked Questions

No. "Taltorvic" was a proposed brand name for ridaforolimus, an mTOR-inhibitor cancer drug. The FDA refused approval in June 2012 after an advisory committee vote against it, and the EU marketing application was withdrawn in November 2012. No regulator has since approved it under any brand name.

Simple Working Process

We have simplified the online drug ordering process into 4 easy steps to ensure
a safe, secure, and hassle-free experience for our customers.


Order Online

Place your order online and upload prescription in minutes with ease.



Order Confirmation

We verify your prescription and confirm your order quickly and securely.



Prescription Review

Reviewed by licensed pharmacists. Carefully processed and validated.

R

Receive Medicines

Approved order delivered fast, easy, and right to your doorstep or nearby Airport.



Global Standards. Trusted Care.

Trusted & Reliable – Your Partner in Global Distribution.

We provide comprehensive lines of pharmaceutical products to support all your healthcare distribution needs.